Literature DB >> 33391258

Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage.

Sandra Bajana1, Kevin Thomas1, Constantin Georgescu2, Ying Zhao1, Jonathan D Wren2, Susan Kovats1, Xiao-Hong Sun1.   

Abstract

Dendritic cell (DC) specification and differentiation are controlled by a circuit of transcription factors, which regulate the expression of DC effector genes as well as the transcription factors themselves. E proteins are a widely expressed basic helix-loop-helix family of transcription factors whose activity is suppressed by their inhibitors, ID proteins. Loss-of-function studies have demonstrated the essential role of both E and ID proteins in different aspects of DC development. In this study, we employed a gain-of-function approach to illustrate the importance of the temporal control of E protein function in maintaining balanced differentiation of conventional DC (cDC) subsets, cDC1 and cDC2. We expressed an E protein mutant, ET2, which dimerizes with endogenous E proteins to overcome inhibition by ID proteins and activate the transcription of E protein targets. Induction of ET2 expression at the hematopoietic progenitor stage led to a dramatic reduction in cDC2 precursors (pre-cDC2s) with little impact on pre-cDC1s. Consequently, we observed decreased numbers of cDC2s in the spleen and lung, as well as in FLT3L-driven bone marrow-derived DC cultures. Furthermore, in mice bearing ET2, we detected increased expression of the IRF8 transcription factor in cDC2s, in which IRF8 is normally down-regulated and IRF4 up-regulated. This aberrant expression of IRF8 induced by ET2 may contribute to the impairment of cDC2 differentiation. In addition, analyses of the transcriptomes of splenic cDC1s and cDC2s revealed that ET2 expression led to a shift, at least in part, of the transcriptional profile characteristic of cDC2s to that of cDC1. Together, these results suggest that a precise control of E protein activity is crucial for balanced DC differentiation.
Copyright © 2020 Bajana, Thomas, Georgescu, Zhao, Wren, Kovats and Sun.

Entities:  

Keywords:  E protein; IRF4; IRF8; cDC1; cDC2; pre-cDC

Mesh:

Substances:

Year:  2020        PMID: 33391258      PMCID: PMC7775562          DOI: 10.3389/fimmu.2020.577718

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  42 in total

1.  Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.

Authors:  Lei Nie; Min Xu; Antoaneta Vladimirova; Xiao-Hong Sun
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

2.  CD8+, CD8-, and plasmacytoid dendritic cell generation in vitro using flt3 ligand.

Authors:  Shalin H Naik; Meredith O'Keeffe; Anna Proietto; Hubertus Hochrein Ken Shortman; Li Wu
Journal:  Methods Mol Biol       Date:  2010

3.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells.

Authors:  Hiyaa S Ghosh; Babacar Cisse; Anna Bunin; Kanako L Lewis; Boris Reizis
Journal:  Immunity       Date:  2010-12-09       Impact factor: 31.745

Review 4.  Organization of the mouse and human DC network.

Authors:  Andreas Schlitzer; Florent Ginhoux
Journal:  Curr Opin Immunol       Date:  2013-12-03       Impact factor: 7.486

5.  Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development.

Authors:  Babacar Cisse; Michele L Caton; Manfred Lehner; Takahiro Maeda; Stefanie Scheu; Richard Locksley; Dan Holmberg; Christiane Zweier; Nicolette S den Hollander; Sarina G Kant; Wolfgang Holter; Anita Rauch; Yuan Zhuang; Boris Reizis
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

Review 6.  Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta.

Authors:  Anita B Roberts; Angelo Russo; Angelina Felici; Kathleen C Flanders
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

7.  An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.

Authors:  Prachi Bagadia; Xiao Huang; Tian-Tian Liu; Vivek Durai; Gary E Grajales-Reyes; Maximilian Nitschké; Zora Modrusan; Jeffrey M Granja; Ansuman T Satpathy; Carlos G Briseño; Marco Gargaro; Arifumi Iwata; Sunkyung Kim; Howard Y Chang; Andrey S Shaw; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2019-08-12       Impact factor: 25.606

8.  Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.

Authors:  Vivek Durai; Prachi Bagadia; Jeffrey M Granja; Ansuman T Satpathy; Devesha H Kulkarni; Jesse T Davidson; Renee Wu; Swapneel J Patel; Arifumi Iwata; Tian-Tian Liu; Xiao Huang; Carlos G Briseño; Gary E Grajales-Reyes; Miriam Wöhner; Hiromi Tagoh; Barbara L Kee; Rodney D Newberry; Meinrad Busslinger; Howard Y Chang; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2019-08-12       Impact factor: 31.250

9.  Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells.

Authors:  S T Park; G P Nolan; X H Sun
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

10.  Notch2-dependent DC2s mediate splenic germinal center responses.

Authors:  Carlos G Briseño; Ansuman T Satpathy; Jesse T Davidson; Stephen T Ferris; Vivek Durai; Prachi Bagadia; Kevin W O'Connor; Derek J Theisen; Theresa L Murphy; Kenneth M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.